Trypanosome transmembrane kinases

锥虫跨膜激酶

基本信息

  • 批准号:
    8605509
  • 负责人:
  • 金额:
    $ 23.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-15 至 2015-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The protozoan parasite Trypanosoma brucei subspecies are the causative agent of African sleeping sickness, a disease that is invariably fatal without treatment. T. brucei has served as a model system for the study of the related trypanosomatid pathogens Trypanosoma cruzi and Leishmania spp., and the three together infect over 12 million people worldwide. The absence of vaccines and the toxic nature of drugs that combat sleeping sickness make research into new drug targets imperative. With the release of the genome sequences of these three trypanosomatids, there are now important decisions as to which of many candidate targets to pursue. Protein kinases are a large class of enzymes that serve as drug targets in cancer and other diseases. They sense the extracellular or intracellular environment and regulate numerous cellular responses, including cell division, responses to stress, development, and death. This project proposes the use of conditional knockout and chemical genetic approaches to examine the roles of protein kinases likely to play a role in host-parasite interactions. We have prioritized two novel protein kinases that reside in T. brucei membranes at the flagellum and flagellar pocket. This region of the parasite plays a prominent role in cell motility and division, nutrient acquisition, and immune evasion mechanisms. Surprisingly, unlike other eukaryotic protein kinases, these kinases possess multiple membrane spanning domains, implying novel modes of information coupling. Our RNAi studies indicate that they are important in the pathogenic bloodstream stage and their location within the parasite predicts a significant role in host-parasite interactions. Conditional knockous of the kinases will firmly establish the role of the kinases in vitro and in a mouse model. A chemical genetic approach using mutant forms of the kinases will be pursued to determine whether specific drug inhibition causes the same phenotypes as absence of the protein, conclusively assessing the suitability of these protein kinases as drug targets and providing the opportunity to dissect the pathways in which the kinases function.
描述(由申请人提供):原生动物寄生虫布鲁氏锥虫亚种是非洲昏睡病的病原体,这是一种未经治疗就会致命的疾病。布鲁氏锥虫是研究相关的锥虫病病原体克氏锥虫和利什曼原虫的模型系统,这三种寄生虫在全世界共有超过1200万人感染。疫苗的缺乏和对抗昏睡病的药物的毒性使得研究新的药物靶点势在必行。随着这三种锥虫的基因组序列的公布,现在有了重要的决定,即在众多候选靶点中选择哪一个。蛋白激酶是一类在癌症和其他疾病中作为药物靶点的酶。它们感知细胞外或细胞内环境并调节许多细胞反应,包括细胞分裂、应激反应、发育和死亡。该项目提出使用条件敲除和化学遗传方法来检查可能在宿主-寄生虫相互作用中发挥作用的蛋白激酶的作用。我们优先考虑了两种新的蛋白激酶,它们存在于

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marilyn Parsons其他文献

Marilyn Parsons的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marilyn Parsons', 18)}}的其他基金

Functional analysis of an essential Trypanosoma brucei protein kinase
布氏锥虫必需蛋白激酶的功能分析
  • 批准号:
    9316312
  • 财政年份:
    2017
  • 资助金额:
    $ 23.63万
  • 项目类别:
Trypanosome transmembrane kinases
锥虫跨膜激酶
  • 批准号:
    8445189
  • 财政年份:
    2013
  • 资助金额:
    $ 23.63万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    8070872
  • 财政年份:
    2010
  • 资助金额:
    $ 23.63万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    7846699
  • 财政年份:
    2009
  • 资助金额:
    $ 23.63万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    7617156
  • 财政年份:
    2007
  • 资助金额:
    $ 23.63万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    7414452
  • 财政年份:
    2007
  • 资助金额:
    $ 23.63万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    7795085
  • 财政年份:
    2007
  • 资助金额:
    $ 23.63万
  • 项目类别:
Mitochondrial Function in Bloodstream Trypanosoma brucei
布氏锥虫血流中的线粒体功能
  • 批准号:
    8064395
  • 财政年份:
    2007
  • 资助金额:
    $ 23.63万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    7622173
  • 财政年份:
    2002
  • 资助金额:
    $ 23.63万
  • 项目类别:
The Plastid of Toxoplasma gondii
弓形虫质体
  • 批准号:
    7795244
  • 财政年份:
    2002
  • 资助金额:
    $ 23.63万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 23.63万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 23.63万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 23.63万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 23.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 23.63万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 23.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了